News

Sangoma and Sphinx Team Up to Revolutionize Healthcare Solutions

Sangoma and Sphinx Team Up to Revolutionize Healthcare Solutions

Transforming Healthcare Communication

Sangoma Technologies Corporation (TSX: STC; Nasdaq: SANG), a leader in business communication solutions, has partnered with Sphinx Medical Technologies. This collaboration aims to tackle a widespread issue in healthcare: outdated and inefficient phone systems. Together, they have launched a new Patient Relationship Management (PRM) system that enhances connectivity between doctors’ offices and patients.

Innovative Integration for Enhanced Patient Care

Sangoma’s unified communications platform now features an integration with Sphinx Medical’s CallMyDoc®, an advanced AI-driven Interactive Voice Response (IVR) system. This integration links calls directly with patient records, allowing for instantaneous access to vital patient information during calls. The system is tailored specifically for the unique requirements of medical practices and works seamlessly with most Electronic Health Records (EHR) systems while ensuring complete HIPAA compliance for secure telehealth services.

Voicing Enthusiasm for the Partnership

Charles Salameh, CEO of Sangoma, expressed enthusiasm about this partnership, stating, "By leveraging CallMyDoc®’s extensive experience with a history of 20 million patient calls alongside Sangoma’s business phone systems, we're redefining communication in healthcare." This initiative emphasizes Sangoma’s commitment to delivering specialized technological solutions, which are crucial to their communication platform strategy.

Key Functionalities of the Sangoma-Sphinx System

The Sangoma-Sphinx PRM system enables medical practices to provide round-the-clock virtual consultations, support multiple languages, and automate follow-up care processes. Moreover, the system enhances revenue generation by increasing operational efficiency, boosting patient retention rates, and creating opportunities for focused marketing of specialized services.

Benefits That Make a Difference

Several key advantages stem from this partnership:

  • Maximum Reliability: With a design aimed at achieving 99.999% uptime, the system guarantees that practices will never miss a call, ensuring constant availability for their patients.
  • Streamlined Operations: Utilizing CallMyDoc®, the system enables real-time access to patient records, automating essential functions like prescription refills and appointment scheduling. With near-perfect AI transcription capabilities, it also streamlines updates to patient charts, saving time on follow-ups.
  • Enhanced Productivity: Transitioning from old-fashioned answering machines to an intelligent auto-attendant allows practices to efficiently manage high call volumes. This innovation reduces average call times drastically without compromising the quality of service.

Enhancing Patient Experiences

Carl Silva, CEO of Sphinx Medical Technologies, emphasized the transformative nature of their collaboration, stating, "This is not just about technology; it's about improving the overall patient experience." They are committed to assisting practices in adapting to the changing demands of contemporary healthcare environments.

Healthcare providers often operate without extensive IT teams to navigate complex systems. This innovative solution is both affordable and scalable, designed to evolve alongside practices without sacrificing performance. Sangoma and its partners pride themselves on offering a premium service experience, delivering sophisticated replacements for telephone systems and personalized configurations, along with comprehensive support.

Broader Benefits for Medical Practices

Practices of all sizes can leverage the advantages of this collaboration, including automated appointment reminders via text and email to minimize patient no-shows. The solution also includes integrated online booking for both primary and specialized care and advanced call routing features with auto-attendants that provide patients 24/7 access to the appropriate departments.

Sangoma and Sphinx Medical are setting a new benchmark in healthcare communication by simplifying processes and enhancing the patient experience. This partnership represents a major advancement in making healthcare more efficient and accessible to both patients and providers.

Availability of the New System

The Sangoma-Sphinx Patient Relationship Management system is now ready for deployment. For additional information, explore the offerings further at sangoma.com/healthcare.

About Sangoma Technologies Corporation

Sangoma is a prominent provider of business communication solutions, encompassing award-winning UCaaS, CCaaS, CPaaS, and Trunking technologies. Their extensive communications suite is developed in-house and is available for cloud, hybrid, and on-premises deployments. Sangoma also provides integrated managed services for connectivity, network, and security, boasting over 40 years of experience in the market.

With more than 2.7 million UC seats and a diversified customer base exceeding 100,000, Sangoma has consistently earned recognition in the Gartner UCaaS Magic Quadrant for ten consecutive years. As a primary developer of the open-source Asterisk and FreePBX projects, Sangoma is dedicated to fostering innovation in communication technology.

About Sphinx Medical Technologies

Sphinx Medical Technologies specializes in creating innovative healthcare solutions aimed at improving operational efficiencies and enhancing patient outcomes. Their mission is to empower healthcare providers, allowing them to prioritize delivering outstanding care.

Frequently Asked Questions

What is the purpose of the partnership between Sangoma and Sphinx Medical?

The partnership aims to enhance healthcare communication by introducing an advanced Patient Relationship Management system that connects doctors’ offices with patients more efficiently.

How does the CallMyDoc® system improve patient care?

CallMyDoc® integrates with patient records, allows for real-time access during calls, and automates numerous tasks, enhancing the overall patient experience.

What are the key benefits of the new system?

Key benefits include 99.999% uptime, streamlined communication, and improved operational efficiency for medical practices.

Who can benefit from the Sangoma-Sphinx PRM system?

Medical practices of all sizes can utilize this system to enhance patient communication, reduce no-shows, and drive revenue through effective marketing strategies.

How has Sangoma been recognized in the communication industry?

Sangoma has been acknowledged in the Gartner UCaaS Magic Quadrant for ten years, highlighting its leadership and innovation in business communications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

XPENG Delivers 39,107 Vehicles in August 2026

Updated Category News Views 11

Grit and Green in XPENG's Latest Numbers You'd think someone at XPENG's HQ popped the champagne today, given what they're reporting, but don't let the buzz fool you. August 2026 saw them deliver 39,107 vehicles. That's a nice 4% tick up year over year. But remember, we're talking a sector where anything short of double digits can feel like a whisper instead of a roar....

Continue Reading
Artivion Set to Announce Financial Results in February 2026

Updated Category News Views 90

Artivion to Announce Fourth Quarter Financial Results Artivion, Inc. (NYSE: AORT), a renowned company in the cardiac and vascular sector, has set a date for the release of its fourth quarter financial results for the year 2025. The main announcement will occur on the afternoon of the market closing on February 12, 2026. This release is highly anticipated within investor...

Continue Reading
FibroBiologics and Charles River Unite for Cell Therapy Advancements

Updated Category News Views 181

FibroBiologics Partners with Charles River for Innovative Therapies FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company, has announced a groundbreaking collaboration with Charles River Laboratories, a renowned name in drug discovery and manufacturing. This partnership aims to develop and manufacture advanced fibroblast cell-based therapies intended to...

Continue Reading
Axsome Therapeutics Looks Ahead with Participations in Events

Updated Category News Views 128

Axsome Therapeutics: Engaging the Investment Community Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical enterprise focused on revolutionary treatments for central nervous system (CNS) disorders, has exciting plans ahead as it prepares to engage with investors at significant upcoming conferences. This engagement highlights the company's commitment...

Continue Reading
Palmstreet's Bold Moves in the $68B Live Shopping Boom

Updated Category News Views 9

Palmstreet Sets the Stage for Seller Success As the live shopping phenomenon in the U.S. rivals the busiest stock market scramble, Palmstreet is laying down some serious game-changing strategies. We're staring at a market expected to hit a staggering $68 billion in 2026, more than doubling its size from three years ago. Instead of riding the coattails of this lucrative...

Continue Reading